Crescent Capital: Q3 Earnings Reinforce Strong Total Return Potential
Crescent Capital's strong dividend coverage and NAV growth indicate a resilient portfolio. The current dividend yield is 9.7% and is well supported by earnings. The portfolio, valued at $1.6B, is concentrated in health care and software, with 97% of debt investments on a floating rate basis. The rate of non-accruals still remains low, showing portfolio company resilience. This highlights CCAP's high-quality underwriting and financial health.
Crescent Capital BDC, Inc. (CCAP) Q3 2024 Earnings Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q3 2024 Earnings Conference Call November 12, 2024 12:00 PM ET Company Participants Dan McMahon - Head, Investor Relations Jason Breaux - Chief Executive Officer Henry Chung - President Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Paul Johnson - KBW Operator Good day, everyone. And welcome to the Third Quarter 2024 Crescent Capital BDC, Inc. Earnings Conference Call.
Crescent Capital BDC (CCAP) Beats Q3 Earnings and Revenue Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.59 per share a year ago.
Crescent Capital: Buy This 9%-Yielding Cash Cow While It's Undervalued
Crescent Capital BDC offers a compelling 9% regular yield and 11% total yield, supported by a diversified portfolio and strong earnings coverage. CCAP's portfolio quality is robust, with a low non-accrual rate and a strong balance sheet. CCAP trades at a material discount to book value and to its larger peers, making it an attractive high-yielding choice for income and value.
Why Crescent Capital BDC (CCAP) Could Beat Earnings Estimates Again
Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Small Cap, Growing BDCs That Could Be Great Income Additions To Your Portfolio
Income investors should consider Crescent Capital BDC and Fidus Investment for their portfolios, as both trade below Net Asset Values and offer growth potential. CCAP, despite a short track record, shows strong investment activity, solid balance sheet, and consistent dividend payouts, making it a defensively positioned growth opportunity. FDUS has a longer track record, impressive dividend growth, and a solid balance sheet with a lower leverage ratio, offering stability and income reliability.
I'm Buying Up To 9% Yield For Recurring Income
An investor's cash flow should be measured alongside net worth as a measure of financial resiliency. Crescent Capital offers an 8.9% yield, focusing on first-lien loans in cash flow-generating, private equity-backed middle-market businesses, with a robust portfolio and strong financials. Federal Realty, a top-tier REIT, provides a 3.9% yield, high-quality mixed-use properties in affluent areas, and a 57-year streak of dividend increases.
Crescent Capital High Yielding Dividends Are Well-Covered Despite Interest Rate Sensitivity
Crescent Capital BDC has a well-diversified, defensive portfolio with 89.2% first-lien debt and decreasing non-accruals, indicating high portfolio quality. CCAP is sensitive to interest rate cuts due to its floating-rate debt investments, but lower interest expenses and increased market activity could somewhat offset this. Despite potential interest rate cuts, CCAP's dividends remain well-covered, with a strong net investment income per share providing robust dividend coverage.
Buy These ‘Private Equity' Plays For 10.5% Yields
Let's talk about a “rich guy loophole” that you and I can take advantage of—and bank dividends up to 12.5%.
Crescent Capital: Strong Cash Flow And The Right Quality For Remaining Bullish
Recently, Crescent Capital has outperformed the BDC market delivering positive returns, while the index has dropped in the negative return territory. Q2, 2024 earnings deck helps explain this, where we can see a continued generation of robust cash flows, solid portfolio quality and improved transaction outlook. In this article, I dissect the Q2 earnings and explain in detail why I have remained bullish.
Crescent Capital BDC, Inc. (CCAP) Q2 2024 Earnings Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q2 2024 Results Conference Call August 13, 2024 12:00 PM ET Company Participants Dan McMahon - Head of Investor Relations Jason Breaux - Chief Executive Officer Henry Chung - President Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Paul Johnson - KBW Finian O'Shea - Wells Fargo Derek Hewett - Bank of America Operator Good day, everyone and welcome to the Q2 2024 Crescent Capital BDC Earnings Conference Call. At this time, all participants are in a listen-only mode.
Crescent Capital BDC (CCAP) Q2 Earnings and Revenues Top Estimates
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.56 per share a year ago.
